Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Ceryvyn Therapeutics Ltd. - Unsponsored ADR (CYVNY) vs ProKidney Corp. (PROK)

Ceryvyn Therapeutics Ltd. - Unsponsored ADR and ProKidney Corp. are both Biotechnology companies. Ceryvyn Therapeutics Ltd. - Unsponsored ADR and ProKidney Corp. are of similar size ($524.8M and $514.0M). ProKidney Corp. has the higher net margin (−10,288.4% vs −89,724.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, ProKidney Corp. leads on 7 and Ceryvyn Therapeutics Ltd. - Unsponsored ADR on 6.

Valuation

Metric CYVNY PROK Biotechnology median
P/E n/m n/m 7.88
P/S 2.37 364.91 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 759.28 143.78 10.73
Earnings yield (2,375.00%) (34.38%) (28.84%)
Free cash flow yield (84,379.36%) (47.41%) (23.03%)

Profitability

Metric CYVNY PROK Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (21,664.55%) 0.00%
Net margin (89,724.18%) (10,288.39%) 0.00%
Free cash flow margin 0.00% (17,300.61%) 0.00%
Return on equity 0.00% 8.92% (57.72%)
Return on assets 0.00% (27.10%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CYVNY PROK Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 61.59% 16.13% —
Revenue growth, 5-year CAGR (15.81%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CYVNY PROK Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.22 8.36 4.73
Net debt to EBITDA 0.31 1.70 0.96

Dividend

Metric CYVNY PROK Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric CYVNY PROK Biotechnology median
Market cap 524.83m 513.95m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack